Affiliations 

  • 1 Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan
  • 2 Medical Research Department, Chi Mei Medical Center, Tainan City, Taiwan
  • 3 Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India
  • 4 Department of Medicine, Thammasat University Hospital, Pathum Thani, Thailand
  • 5 Department of Medicine, Section of Infectious Diseases, Hospital Infection Control and Epidemiology Center, The Medical City, Pasig City, Philippines
  • 6 Department of Pharmacy, Singapore General Hospital, Singapore, Singapore
  • 7 Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
  • 8 Department of Medical Microbiology and Parasitology, School of Medical Sciences/Hospital Universiti Sains Malaysia, USM Health Campus, Kubang Kerian, Kelantan, Malaysia
  • 9 Medical Development Division, Ministry of Health, Putrajaya, Malaysia
  • 10 Pharmacy Practice and Development Division, Ministry of Health, Petaling Jaya, Malaysia
  • 11 Department of Microbiology, Medical Faculty, Universitas Indonesia, Jakarta, Indonesia
  • 12 Department of Pathology/Microbiology, Pakistan Kidney and Liver Institute, Lahore, Pakistan
  • 13 Department of Infectious Diseases, International University of Health and Welfare, Chiba-ken, Japan
  • 14 Infectious Diseases Department, Hanoi Medical University, Hanoi, Vietnam
  • 15 Emergency Department - Infection Control, National Hospital for Tropical Diseases, Hanoi, Vietnam
JAC Antimicrob Resist, 2022 Dec;4(6):dlac117.
PMID: 36439993 DOI: 10.1093/jacamr/dlac117

Abstract

OBJECTIVES: To determine antimicrobial stewardship (AMS) programme practices in Asian secondary- and tertiary-care hospitals.

METHODS: AMS programme team members within 349 hospitals from 10 countries (Cambodia, India, Indonesia, Japan, Malaysia, Pakistan, the Philippines, Taiwan, Thailand and Vietnam) completed a questionnaire via a web-based survey link. The survey contained questions as to whether 12 core components deemed essential for AMS programmes were implemented.

RESULTS: Overall, 47 (13.5%) hospitals fulfilled all core AMS programme components. There was a mean positive response rate (PRR) of 85.6% for the responding countries in relation to a formal hospital leadership statement of support for AMS activities, but this was not matched by budgeted financial support for AMS activities (mean PRR 57.1%). Mean PRRs were ≥80.0% for the core AMS team comprising a physician or other leader responsible for AMS activities, a pharmacist and infection control and microbiology personnel. Most hospitals had access to a timely and reliable microbiology service (mean PRR 90.4%). Facility-specific antibiotic treatment guidelines for common infections (mean PRR 78.7%) were in place more often than pre-authorization and/or prospective audit and feedback systems (mean PRR 66.5%). In terms of AMS monitoring and reporting, PRRs of monitoring specific antibiotic use, regularly publishing AMS outcome measures, and the existence of a hospital antibiogram were 75.1%, 64.4% and 77.9%, respectively.

CONCLUSIONS: Most hospitals participating in this survey did not have AMS programmes fulfilling the requirements for gold standard AMS programmes in hospital settings. Urgent action is required to address AMS funding and resourcing deficits.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.